Product Information
OXTELLAR XR 600 MG TABLET is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $23.2026 per EA under NDC 17772012301. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the OXCARBAZEPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
600 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772012301
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA202810FDA Approved
10/19/2012
TE Code
AB
On Market Since
1/17/2013
Pharmacological Classes
Price Statistics
The NADAC for OXTELLAR XR 600 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 217.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.2026 per EA |
|---|---|
| All-time high | $23.2967 (Sep 10, 2025) |
| All-time low | $7.3069 (Nov 28, 2013) |
| 52-week high | $23.2967 |
| 52-week low | $23.1909 |
| Median price | $17.4253 |
| Average price | $16.6356 |
| Largest weekly change | +13.9% (Jul 23, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXTELLAR XR 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXTELLAR XR 600 MG TABLET, manufactured by Supernus Pharmaceuticals Inc., is $23.2026 per EA (NDC 17772012301), effective Aug 19, 2026.
How has the price of OXTELLAR XR 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXTELLAR XR 600 MG TABLET has risen 217.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXTELLAR XR 600 MG TABLET?
Since Nov 28, 2013, the NADAC for OXTELLAR XR 600 MG TABLET has ranged from a low of $7.3069 (Nov 28, 2013) to a high of $23.2967 (Sep 10, 2025), with a median of $17.4253 per EA.
Are there cheaper alternatives to OXTELLAR XR 600 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 600 MG TABLET, is $0.3130 per EA — about 99% below OXTELLAR XR 600 MG TABLET.
Who manufactures OXTELLAR XR 600 MG TABLET?
OXTELLAR XR 600 MG TABLET (NDC 17772012301) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.